查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
糖尿病治療設備的全球市場 - 規模、佔有率、產業趨勢分析:各產品、各地區的展望及預測(2022年～2028年)
市場調查報告書
商品編碼
1093278

糖尿病治療設備的全球市場 - 規模、佔有率、產業趨勢分析:各產品、各地區的展望及預測(2022年～2028年)

Global Diabetes Care Devices Market Size, Share & Industry Trends Analysis Report By Product (Insulin Delivery Devices and Blood Glucose Monitoring Devices), By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 127 Pages | 訂單完成後即時交付

價格

全球糖尿病治療設備的市場規模，預計至2028年達到293億美元，在預測期間內以5.6％的年複合成長率成長。市場成長要素是罹患率的上升，治療的技術性強化等。

本報告提供全球糖尿病治療設備市場相關調查分析，市場市場概要，各市場區隔的市場分析，各地區的市場分析，主要企業等相關的系統性資訊。

目錄

第1章 市場範圍與調查手法

第2章 市場概要

  • 簡介
  • 影響市場的主要原因

第3章 全球競爭分析

  • KBV Cardinal Matrix
  • 最近的產業整體策略性開發
  • 主要的成功策略

第4章 全球糖尿病治療設備市場:各產品

  • 全球胰島素輸送設備市場:各地區
  • 全球血糖監測系統設備市場:各地區

第5章 全球糖尿病治療設備市場:各地區

  • 北美的糖尿病治療設備市場
  • 歐洲的糖尿病治療設備市場
  • 亞太地區的糖尿病治療設備市場
  • 南美、中東、非洲的糖尿病治療設備市場

第6章 企業簡介

  • F. Hoffmann-La Roche Ltd.
  • DexCom, Inc.
  • Novo Nordisk A/S
  • Sanofi S.A.
  • Zealand Pharma A/S (Valeritas, Inc.)
  • B. Braun Melsungen AG
  • Bayer AG
  • Abbott Laboratories
  • Ypsomed AG
  • Arkray, Inc.

The Global Diabetes Care Devices Market size is expected to reach $29.3 billion by 2028, rising at a market growth of 5.6% CAGR during the forecast period.

Diabetes is a condition in which blood glucose levels rise above standard due to a malfunction in insulin synthesis, which regulates glucose levels. The main source of energy is blood glucose, which is derived from the food people consumes. Insulin, a pancreatic hormone, keeps blood glucose levels in control. Diabetes is caused by a deficiency in the manufacture of insulin in the body, which makes it unable to control blood glucose levels. Normal blood glucose levels range from 70 to 100 mg/dL, while diabetic patients' levels range from 80 to 130 mg/dL. Diabetes care gadgets are used to keep track of a diabetic's blood glucose levels. A continuous glucose monitor is a medical gadget that continuously tracks and monitors a diabetic patient's blood glucose levels throughout the day. People with diabetes would benefit from this wearable device since it can help them in managing their glucose levels. Ketone monitors, insulin pumps, blood glucose monitors, continuous glucose monitors, smart insulin pens, as well as diabetes management applications are all examples of diabetic monitoring devices. Glucose monitoring devices aid in the maintenance and control of glucose levels, hence enhancing the patient's health.

According to the American Diabetes Association, the organization is adding a special section on diabetes technology to the Standards of Medical Care in Diabetes for the first time to provide more clarity in the diabetes technology space. The section would focus on insulin delivery along with glucose monitoring with the most popular tools currently in use for this first authoring. This section would be updated in the coming years to incorporate topics like software as a medical device, cost, privacy, technology-enabled diabetes education and support, telemedicine, and other issues that physicians and patients face when using technology in modern diabetes treatment.

Abbott and Novo Nordisk formed non-exclusive cooperation in February 2019. This collaboration is intended to improve diabetes digital solutions. The data collected by Novo Nordisk prefilled durable linked pens will be represented in the digitally connected FreeStyle Libre system via the FreeStyle LibreLink mobile app and the LibreView cloud-based system as part of this agreement. Healthcare practitioners can study both glucose and insulin data simultaneously thanks to this technology integration, which could make diabetes management easier.

COVID-19 Impact

The COVID-19 pandemic had a positive impact on the diabetes care devices market. This was due to the fact that people with various health concerns, such as diabetes and high blood pressure, were more likely to contract the virus. Patients with diabetes had a higher mortality rate than the overall population. Diabetes patients require constant insulin administration (through syringes or pens) and care. As a result of the widespread use of insulin pens and constant glucose monitoring devices, the demand for close diabetes monitoring and care was increased. In addition, diabetic patients are more likely to contract COVID-19, which is driving up demand for diabetes devices in both hospital and home care settings. Diabetes devices are in growing demand because they help diabetic people avoid lengthier hospital stays as well as higher mortality rates.

Market Growth Factors

Rising incidences of diabetes across the world

The number of people with diabetes is rapidly increasing all over the world in recent years. It is becoming one of the deadliest diseases in the worldwide population. Diabetes and its consequences were estimated to kill around 4 million people aged 20 to 79 years in 2020. This corresponds to one death every eight seconds. Diabetes is considered to be responsible for 11.3% of all fatalities among adults in this age group worldwide. According to the American Association of Clinical Endocrinologists, recent research has found that 22.2 percent to 26.9% of people hospitalized for the serious condition have diabetes. In hospitalized Coronavirus patients, diabetes and high glucose levels are linked to increased health problems, respiratory failure, and fatality.

An increasing number of technological enhancements in diabetes care approaches

In the modern era, various advanced and next-gen technologies are being introduced all over the world. In the healthcare sector, technology is becoming an essential part of processes, increasing its demand. Moreover, technology is also playing a major role in enhancing the life quality of people. The integration of new and advanced technologies in diabetes care devices is increasing the efficiency and precision of these devices. One of the primary factors driving the diabetes care devices market is the introduction of novel technologies and products in diabetes monitoring treatment devices and systems. Various market players are significantly increasing their investments in bringing several technology-rich diabetes care devices, which is increasing the demand for these products across people.

Market Restraining Factors

The increased cost of artificial insulin

In diabetes treatment, artificial insulin is used in order to help the body to eliminate excess blood glucose levels that the body itself is not capable to eliminate. Artificial insulin is injected into the body of the patient through a computed or a regular syringe. The market shift from relatively low-cost human insulin to more expensive analogs (synthetic insulins) is putting unbearable financial strain on low-income countries. Human insulin is equally effective as analogs in most cases, but analogs are at least 1.5 times more expensive, and in certain cases three times more expensive. Three multinational businesses control more than 90% of the insulin industry, leaving little room for smaller companies to compete in terms of sales. Insulin costs in the world are increasing, compelling diabetics and their families to make difficult decisions.

Product Outlook

Based on Product, the market is segmented into Insulin Delivery Devices and Blood Glucose Monitoring Devices. In 2021, the insulin delivery devices segment acquired the largest revenue share of the diabetes care devices market. The growth of this segment is attributed to a number of factors, including an increase in the adoption of unhealthy lifestyles and an increase in the prevalence of type 1 as well as type 2 diabetes around the world.

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. In 2021, North America accounted for the largest revenue share of the diabetes care devices market. The rising growth of the regional market is owing to the rising prevalence of diabetes, rising healthcare expenditures, and the increased presence of important insulin syringe manufacturers. In addition, the early adoption of technologies in this region is also a major factor that is estimated to derive the regional market during the forecast period.

The major strategies followed by the market participants are Partnerships. Based on the Analysis presented in the Cardinal matrix; F. Hoffmann-La Roche Ltd. is the forerunner in the Diabetes Care Devices Market. Companies such as Novo Nordisk A/S, Abbott Laboratories and Sanofi S.A. are some of the key innovators in the Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., DexCom, Inc., Novo Nordisk A/S, Sanofi S.A., Zealand Pharma A/S, B. Braun Melsungen AG, Bayer AG, Abbott Laboratories, Ypsomed AG, Arkray, Inc.

Recent Strategies deployed in Diabetes Care Devices Market

Partnerships, Collaborations and Agreement:

May-2022: ARKRAY partnered with Rimidi, a leader in the clinical management platform. Under this partnership, the companies aimed to integrate ARKRAY's GLUCOCARD Shine Connex Blood Glucose Monitoring System into the Rimidi Platform to optimize blood glucose data for patients and doctors. In addition, this partnership would also offer a deep insight into patients' blood glucose data to doctors, which would derive more informed clinical decisions.

Apr-2022: Abbott, partnered with Ypsomed, a leader in developing injection and infusion systems. Through this partnership, the companies aimed to develop and market an integrated automated insulin delivery in order to help in reducing the burden of diabetes management for diabetic patients by offering a product that eliminates the requirement for insulin injection at every particular time period.

Apr-2022: Roche Diabetes Care India came into a partnership with Fitterfly Healthtech, a leading Digital Therapeutics company in India. Through this partnership, the companies aimed to launch a 90-day diabetes management program for patients with type 2 diabetes in order to improve therapy adherence and enhance outcomes.

Mar-2022: Ypsomed came into a partnership with CamDiab, a personalized medicine, and digital health company. Through this partnership, the companies aimed to roll out CamAPS FX in order to allow diabetic people to manage their automated insulin delivery through a mobile app.

Mar-2022: Sanofi signed a five-year agreement with DarioHealth, a digital health company. Following this agreement, Sanofi would ingrate its product on Dario's platform. Moreover, Dario would leverage Sanofi's sales teams in order to market its prevailing products.

Jan-2022: Roche partnered with Glytec, an insulin management software company. Following this partnership, Glytec's Glucommander would be integrated into the newly launched Cobas pulse of Roche to benefit numerous hospital patients and doctors.

Oct-2021: Roche teamed up with Zur Rose Group, an e-commerce pharmacy. Under this collaboration, the companies would mutually focus on optimizing the daily therapy management of diabetic patients along with their doctors.

Oct-2021: Dexcom partnered with LovedBy, a consultancy and technology company. With this partnership, the companies aimed to bring personalized and contextual educational content to young patients with Type-1 diabetes in order to help them in coping with their condition.

Sep-2021: Novo Nordisk came into an agreement with BIOCORP, an innovative medical devices company. Following this agreement, the companies would focus on developing and commercializing a Mallya smart add-on device for the FlexTouch pen of Novo Nordisk.

May-2021: Roche entered into an agreement with Eli Lilly and Company, a leader in diabetes care solutions. Following this agreement, the companies would increase their efforts in boosting the optimization of insulin pen therapy management.

Arp-2021: Dexcom came into a partnership with Welldoc, a leader in digital health. With this partnership, the companies aimed to incorporate the impact of lifestyle choices with glucose monitoring in order to enhance the health of patients with Type-2 diabetes.

Mar-2021: Roche signed a multi-year research collaboration and licensing agreement with SemaThera, a biotech company. With this agreement, the companies aimed to focus on the development of SemaThera's new category of biologicals to cure diabetic retinopathy along with other ischemic retinal diseases.

Nov-2020: Ypsomed came into an agreement with Eli Lilly, a pharmaceutical company. Following this agreement, the companies aimed to develop an automated insulin delivery system to regulate blood glucose levels in people with diabetes. Moreover, Eli Lilly would commercialize the new automated insulin delivery system across the US as well as the European market.

Sep-2020: Sanofi partnered with Health2Sync, a digital health startup. Under this partnership, Health2Sync would offer digital solutions, including patient management software and a mobile app, to 300 hospitals and clinics contracted by Sanofi with the aim to provide digitized and integrated digitized diabetes management.

Sep-2020: DexCom entered into a five-year collaboration agreement with the University of Virginia, a public research university. Through this agreement, the companies aimed to accelerate its R&D efforts on CGM-based solutions to advance the automated insulin delivery technology of Dexcom.

Jun-2020: Abbott signed an agreement with Tandem Diabetes Care, a medical device manufacturer. Following this agreement, the companies would manufacture and market integrated diabetes solutions with the integration of Tandem's innovative insulin delivery systems and the world-leading continuous glucose monitoring technology of Abbott.

May-2020: Bayer signed a commercial agreement with WaveForm Technologies, a subsidiary of AgaMatrix. Through this agreement, the companies aimed to offer innovative and advanced glucose monitoring solutions to doctors and patients across China.

Apr-2020: Ypsomed came into a partnership with DexCom, a leader in providing CGM systems. Under this partnership, the companies would develop a hybrid closed loop system with the full integration of the therapy management solution of Ypsomed and Dexcom's G6 sensors-derived glucose values.

Feb-2020: DexCom signed a global commercialization agreement with Insulet Corporation, a medical device company. Under this agreement, the companies would integrate future and current continuous glucose monitoring systems of Dexcom with Insulet's best-in-class tubeless insulin delivery Pod into the Omnipod Horizon System for automated insulin delivery.

Feb-2020: DexCom partnered with DreaMed Diabetes, a personalized diabetes management solutions developer. This partnership would allow a seamless CGM data transfer from Dexcom to DreaMed Advisor.

Feb-2020: Abbott teamed up with Insulet, a medical device company. Through this collaboration, the companies aimed to integrate the blood glucose sensing technology of Abbott into Insulet's Omnipod Horizon automated insulin delivery system in order to deliver automated and customized insulin delivery to diabetic patients.

Product Launches and Product Expansions:

May-2022: Roche released ACCU-FINE, quality pen needles. This launch aimed to streamline the process of delivering insulin to provide better diabetes management to patients with diabetes.

Apr-2022: DexCom rolled out its ONE Continuous Glucose Monitoring in the UK. Through this launch, the company aimed to offer a real-time CGM at more affordable rates. Moreover, the new system would be more accessible to diabetics across the UK.

Aug-2021: Zealand Pharma rolled out ZEGALOGUE Injection in the US. With this launch, the company aimed to advance its pipeline programs in distinct therapeutic sectors. In addition, the new product is commercialized in both prefilled syringes and auto-injector forms for the treatment of patients with severe hypoglycemia aged above 6 years.

Mar-2021: Roche rolled out the Accu-Chek Instant system, a connected blood glucose monitoring system. The new product would enable and support the integrated Personalised Diabetes Management approach of Roche, a holistic patient-centered therapeutic approach.

Acquisitions and Mergers:

Dec-2021: Novo Nordisk completed its acquisition of Dicerna Pharmaceuticals, a biopharmaceutical company. Through this acquisition, the company aimed to integrate Dicerna's ribonucleic acid interference platform into its prevailing research technology platforms to complement its vision of leveraging a wide line of technology platforms applicable all over Novo Nordisk's therapeutic focus areas.

Approvals and Trials:

Feb-2022: Bayer received the EU approval for its Kerendia, a new treatment for adult patients with chronic kidney disease linked with type 2 diabetes. This approval aimed to offer a solution to physicians in order to reduce the risk of cardiovascular incidents while delaying the progression of kidney disease in patients.

Aug-2021: Abbott received the US FDA approval for its FreeStyle Libre 2 iOS application, an application for measuring glucose levels to regulate diabetes. Through this approval, the company aimed to offer a cost-effective and accessible glucose monitoring application based on the sensor to allow users to check their glucose levels on their iPhones.

May-2021: Zealand Pharma received the FDA approval for its Zegalogue injection. Following this approval, the company would commercialize Zegalogue in order to help diabetic people in recovering from severe hypoglycemia.

Scope of the Study

Market Segments covered in the Report:

By Product

  • Insulin Delivery Devices and
  • Blood Glucose Monitoring Devices

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • F. Hoffmann-La Roche Ltd.
  • DexCom, Inc.
  • Novo Nordisk A/S
  • Sanofi S.A.
  • Zealand Pharma A/S
  • B. Braun Melsungen AG
  • Bayer AG
  • Abbott Laboratories
  • Ypsomed AG
  • Arkray, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Diabetes Care Devices Market, by Product
    • 1.4.2 Global Diabetes Care Devices Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
    • 3.2.4 Geographical Expansions
    • 3.2.5 Approvals and Trials
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
    • 3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements : 2018, Oct - 2022, May) Leading Players

Chapter 4. Global Diabetes Care Devices Market by Product

  • 4.1 Global Insulin Delivery Devices Market by Region
  • 4.2 Global Blood Glucose Monitoring Devices Market by Region

Chapter 5. Global Diabetes Care Devices Market by Region

  • 5.1 North America Diabetes Care Devices Market
    • 5.1.1 North America Diabetes Care Devices Market by Product
      • 5.1.1.1 North America Insulin Delivery Devices Market by Country
      • 5.1.1.2 North America Blood Glucose Monitoring Devices Market by Country
    • 5.1.2 North America Diabetes Care Devices Market by Country
      • 5.1.2.1 US Diabetes Care Devices Market
        • 5.1.2.1.1 US Diabetes Care Devices Market by Product
      • 5.1.2.2 Canada Diabetes Care Devices Market
        • 5.1.2.2.1 Canada Diabetes Care Devices Market by Product
      • 5.1.2.3 Mexico Diabetes Care Devices Market
        • 5.1.2.3.1 Mexico Diabetes Care Devices Market by Product
      • 5.1.2.4 Rest of North America Diabetes Care Devices Market
        • 5.1.2.4.1 Rest of North America Diabetes Care Devices Market by Product
  • 5.2 Europe Diabetes Care Devices Market
    • 5.2.1 Europe Diabetes Care Devices Market by Product
      • 5.2.1.1 Europe Insulin Delivery Devices Market by Country
      • 5.2.1.2 Europe Blood Glucose Monitoring Devices Market by Country
    • 5.2.2 Europe Diabetes Care Devices Market by Country
      • 5.2.2.1 Germany Diabetes Care Devices Market
        • 5.2.2.1.1 Germany Diabetes Care Devices Market by Product
      • 5.2.2.2 UK Diabetes Care Devices Market
        • 5.2.2.2.1 UK Diabetes Care Devices Market by Product
      • 5.2.2.3 France Diabetes Care Devices Market
        • 5.2.2.3.1 France Diabetes Care Devices Market by Product
      • 5.2.2.4 Russia Diabetes Care Devices Market
        • 5.2.2.4.1 Russia Diabetes Care Devices Market by Product
      • 5.2.2.5 Spain Diabetes Care Devices Market
        • 5.2.2.5.1 Spain Diabetes Care Devices Market by Product
      • 5.2.2.6 Italy Diabetes Care Devices Market
        • 5.2.2.6.1 Italy Diabetes Care Devices Market by Product
      • 5.2.2.7 Rest of Europe Diabetes Care Devices Market
        • 5.2.2.7.1 Rest of Europe Diabetes Care Devices Market by Product
  • 5.3 Asia Pacific Diabetes Care Devices Market
    • 5.3.1 Asia Pacific Diabetes Care Devices Market by Product
      • 5.3.1.1 Asia Pacific Insulin Delivery Devices Market by Country
      • 5.3.1.2 Asia Pacific Blood Glucose Monitoring Devices Market by Country
    • 5.3.2 Asia Pacific Diabetes Care Devices Market by Country
      • 5.3.2.1 China Diabetes Care Devices Market
        • 5.3.2.1.1 China Diabetes Care Devices Market by Product
      • 5.3.2.2 Japan Diabetes Care Devices Market
        • 5.3.2.2.1 Japan Diabetes Care Devices Market by Product
      • 5.3.2.3 India Diabetes Care Devices Market
        • 5.3.2.3.1 India Diabetes Care Devices Market by Product
      • 5.3.2.4 South Korea Diabetes Care Devices Market
        • 5.3.2.4.1 South Korea Diabetes Care Devices Market by Product
      • 5.3.2.5 Singapore Diabetes Care Devices Market
        • 5.3.2.5.1 Singapore Diabetes Care Devices Market by Product
      • 5.3.2.6 Malaysia Diabetes Care Devices Market
        • 5.3.2.6.1 Malaysia Diabetes Care Devices Market by Product
      • 5.3.2.7 Rest of Asia Pacific Diabetes Care Devices Market
        • 5.3.2.7.1 Rest of Asia Pacific Diabetes Care Devices Market by Product
  • 5.4 LAMEA Diabetes Care Devices Market
    • 5.4.1 LAMEA Diabetes Care Devices Market by Product
      • 5.4.1.1 LAMEA Insulin Delivery Devices Market by Country
      • 5.4.1.2 LAMEA Blood Glucose Monitoring Devices Market by Country
    • 5.4.2 LAMEA Diabetes Care Devices Market by Country
      • 5.4.2.1 Brazil Diabetes Care Devices Market
        • 5.4.2.1.1 Brazil Diabetes Care Devices Market by Product
      • 5.4.2.2 Argentina Diabetes Care Devices Market
        • 5.4.2.2.1 Argentina Diabetes Care Devices Market by Product
      • 5.4.2.3 UAE Diabetes Care Devices Market
        • 5.4.2.3.1 UAE Diabetes Care Devices Market by Product
      • 5.4.2.4 Saudi Arabia Diabetes Care Devices Market
        • 5.4.2.4.1 Saudi Arabia Diabetes Care Devices Market by Product
      • 5.4.2.5 South Africa Diabetes Care Devices Market
        • 5.4.2.5.1 South Africa Diabetes Care Devices Market by Product
      • 5.4.2.6 Nigeria Diabetes Care Devices Market
        • 5.4.2.6.1 Nigeria Diabetes Care Devices Market by Product
      • 5.4.2.7 Rest of LAMEA Diabetes Care Devices Market
        • 5.4.2.7.1 Rest of LAMEA Diabetes Care Devices Market by Product

Chapter 6. Company Profiles

  • 6.1 F. Hoffmann-La Roche Ltd.
    • 6.1.1 Company Overview
    • 6.1.2 Financial Analysis
    • 6.1.3 Segmental and Regional Analysis
    • 6.1.4 Research & Development Expense
    • 6.1.5 Recent strategies and developments:
      • 6.1.5.1 Partnerships, Collaborations, and Agreements:
      • 6.1.5.2 Product Launches and Product Expansions:
  • 6.2 DexCom, Inc.
    • 6.2.1 Company Overview
    • 6.2.2 Financial Analysis
    • 6.2.3 Regional Analysis
    • 6.2.4 Research & Development Expenses
    • 6.2.5 Recent strategies and developments:
      • 6.2.5.1 Partnerships, Collaborations, and Agreements:
      • 6.2.5.2 Product Launches and Product Expansions:
      • 6.2.5.3 Acquisition and Mergers:
  • 6.3 Novo Nordisk A/S
    • 6.3.1 Company Overview
    • 6.3.2 Financial Analysis
    • 6.3.3 Segmental & Regional Analysis
    • 6.3.4 Research & Development Expenses
    • 6.3.5 Recent strategies and developments:
      • 6.3.5.1 Partnerships, Collaborations, and Agreements:
      • 6.3.5.2 Acquisition and Mergers:
  • 6.4 Sanofi S.A.
    • 6.4.1 Company Overview
    • 6.4.2 Financial Analysis
    • 6.4.3 Segmental and Regional Analysis
    • 6.4.4 Research & Development Expense
    • 6.4.5 Recent strategies and developments:
      • 6.4.5.1 Partnerships, Collaborations, and Agreements:
      • 6.4.5.2 Product Launches and Product Expansions:
  • 6.5 Zealand Pharma A/S (Valeritas, Inc.)
    • 6.5.1 Company Overview
    • 6.5.2 Financial Analysis
    • 6.5.3 Research & Development Expenses
    • 6.5.4 Recent strategies and developments:
      • 6.5.4.1 Product Launches and Product Expansions:
      • 6.5.4.2 Approvals and Trials:
  • 6.6 B. Braun Melsungen AG
    • 6.6.1 Company Overview
    • 6.6.2 Financial Analysis
    • 6.6.3 Segmental and Regional Analysis
    • 6.6.4 Research & Development Expenses
    • 6.6.5 Recent strategies and developments:
      • 6.6.5.1 Partnerships, Collaborations, and Agreements:
  • 6.7 Bayer AG
    • 6.7.1 Company Overview
    • 6.7.2 Financial Analysis
    • 6.7.3 Segmental and Regional Analysis
    • 6.7.4 Research & Development Expense
    • 6.7.5 Recent strategies and developments:
      • 6.7.5.1 Partnerships, Collaborations, and Agreements:
      • 6.7.5.2 Approvals:
  • 6.8 Abbott Laboratories
    • 6.8.1 Company Overview
    • 6.8.2 Financial Analysis
    • 6.8.3 Segmental and Regional Analysis
    • 6.8.4 Research & Development Expense
    • 6.8.5 Recent strategies and developments:
      • 6.8.5.1 Partnerships, Collaborations, and Agreements:
      • 6.8.5.2 Approvals:
  • 6.9 Ypsomed AG
    • 6.9.1 Company Overview
    • 6.9.2 Financial Analysis
    • 6.9.3 Segmental and Regional Analysis
    • 6.9.4 Recent strategies and developments:
      • 6.9.4.1 Partnerships, Collaborations, and Agreements:
  • 6.10. Arkray, Inc.
    • 6.10.1 Company Overview
    • 6.10.2 Recent strategies and developments:
      • 6.10.2.1 Partnerships, Collaborations, and Agreements:
      • 6.10.2.2 Geographical Expansions:

LIST OF TABLES

  • TABLE 1 Global Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 2 Global Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Diabetes Care Devices Market
  • TABLE 4 Product Launches And Product Expansions- Diabetes Care Devices Market
  • TABLE 5 Acquisition and Mergers- Diabetes Care Devices Market
  • TABLE 6 Geographical expansion- Diabetes Care Devices Market
  • TABLE 7 Approvals and Trials- Diabetes Care Devices Market
  • TABLE 8 Global Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 9 Global Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 10 Global Insulin Delivery Devices Market by Region, 2018 - 2021, USD Million
  • TABLE 11 Global Insulin Delivery Devices Market by Region, 2022 - 2028, USD Million
  • TABLE 12 Global Blood Glucose Monitoring Devices Market by Region, 2018 - 2021, USD Million
  • TABLE 13 Global Blood Glucose Monitoring Devices Market by Region, 2022 - 2028, USD Million
  • TABLE 14 Global Diabetes Care Devices Market by Region, 2018 - 2021, USD Million
  • TABLE 15 Global Diabetes Care Devices Market by Region, 2022 - 2028, USD Million
  • TABLE 16 North America Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 17 North America Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 18 North America Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 19 North America Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 20 North America Insulin Delivery Devices Market by Country, 2018 - 2021, USD Million
  • TABLE 21 North America Insulin Delivery Devices Market by Country, 2022 - 2028, USD Million
  • TABLE 22 North America Blood Glucose Monitoring Devices Market by Country, 2018 - 2021, USD Million
  • TABLE 23 North America Blood Glucose Monitoring Devices Market by Country, 2022 - 2028, USD Million
  • TABLE 24 North America Diabetes Care Devices Market by Country, 2018 - 2021, USD Million
  • TABLE 25 North America Diabetes Care Devices Market by Country, 2022 - 2028, USD Million
  • TABLE 26 US Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 27 US Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 28 US Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 29 US Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 30 Canada Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 31 Canada Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 32 Canada Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 33 Canada Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 34 Mexico Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 35 Mexico Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 36 Mexico Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 37 Mexico Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 38 Rest of North America Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 39 Rest of North America Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 40 Rest of North America Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 41 Rest of North America Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 42 Europe Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 43 Europe Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 44 Europe Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 45 Europe Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 46 Europe Insulin Delivery Devices Market by Country, 2018 - 2021, USD Million
  • TABLE 47 Europe Insulin Delivery Devices Market by Country, 2022 - 2028, USD Million
  • TABLE 48 Europe Blood Glucose Monitoring Devices Market by Country, 2018 - 2021, USD Million
  • TABLE 49 Europe Blood Glucose Monitoring Devices Market by Country, 2022 - 2028, USD Million
  • TABLE 50 Europe Diabetes Care Devices Market by Country, 2018 - 2021, USD Million
  • TABLE 51 Europe Diabetes Care Devices Market by Country, 2022 - 2028, USD Million
  • TABLE 52 Germany Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 53 Germany Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 54 Germany Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 55 Germany Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 56 UK Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 57 UK Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 58 UK Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 59 UK Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 60 France Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 61 France Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 62 France Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 63 France Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 64 Russia Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 65 Russia Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 66 Russia Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 67 Russia Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 68 Spain Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 69 Spain Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 70 Spain Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 71 Spain Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 72 Italy Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 73 Italy Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 74 Italy Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 75 Italy Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 76 Rest of Europe Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 77 Rest of Europe Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 78 Rest of Europe Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 79 Rest of Europe Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 80 Asia Pacific Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 81 Asia Pacific Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 82 Asia Pacific Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 83 Asia Pacific Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 84 Asia Pacific Insulin Delivery Devices Market by Country, 2018 - 2021, USD Million
  • TABLE 85 Asia Pacific Insulin Delivery Devices Market by Country, 2022 - 2028, USD Million
  • TABLE 86 Asia Pacific Blood Glucose Monitoring Devices Market by Country, 2018 - 2021, USD Million
  • TABLE 87 Asia Pacific Blood Glucose Monitoring Devices Market by Country, 2022 - 2028, USD Million
  • TABLE 88 Asia Pacific Diabetes Care Devices Market by Country, 2018 - 2021, USD Million
  • TABLE 89 Asia Pacific Diabetes Care Devices Market by Country, 2022 - 2028, USD Million
  • TABLE 90 China Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 91 China Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 92 China Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 93 China Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 94 Japan Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 95 Japan Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 96 Japan Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 97 Japan Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 98 India Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 99 India Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 100 India Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 101 India Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 102 South Korea Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 103 South Korea Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 104 South Korea Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 105 South Korea Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 106 Singapore Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 107 Singapore Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 108 Singapore Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 109 Singapore Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 110 Malaysia Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 111 Malaysia Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 112 Malaysia Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 113 Malaysia Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 114 Rest of Asia Pacific Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 115 Rest of Asia Pacific Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 116 Rest of Asia Pacific Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 117 Rest of Asia Pacific Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 118 LAMEA Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 119 LAMEA Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 120 LAMEA Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 121 LAMEA Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 122 LAMEA Insulin Delivery Devices Market by Country, 2018 - 2021, USD Million
  • TABLE 123 LAMEA Insulin Delivery Devices Market by Country, 2022 - 2028, USD Million
  • TABLE 124 LAMEA Blood Glucose Monitoring Devices Market by Country, 2018 - 2021, USD Million
  • TABLE 125 LAMEA Blood Glucose Monitoring Devices Market by Country, 2022 - 2028, USD Million
  • TABLE 126 LAMEA Diabetes Care Devices Market by Country, 2018 - 2021, USD Million
  • TABLE 127 LAMEA Diabetes Care Devices Market by Country, 2022 - 2028, USD Million
  • TABLE 128 Brazil Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 129 Brazil Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 130 Brazil Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 131 Brazil Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 132 Argentina Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 133 Argentina Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 134 Argentina Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 135 Argentina Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 136 UAE Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 137 UAE Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 138 UAE Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 139 UAE Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 140 Saudi Arabia Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 141 Saudi Arabia Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 142 Saudi Arabia Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 143 Saudi Arabia Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 144 South Africa Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 145 South Africa Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 146 South Africa Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 147 South Africa Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 148 Nigeria Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 149 Nigeria Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 150 Nigeria Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 151 Nigeria Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 152 Rest of LAMEA Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 153 Rest of LAMEA Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 154 Rest of LAMEA Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 155 Rest of LAMEA Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 156 KEY INFORMATION - F. HOFFMANN-LA ROCHE LTD.
  • TABLE 157 Key Information - DexCom, Inc.
  • TABLE 158 Key information - Novo Nordisk A/S
  • TABLE 159 Key Information - Sanofi S.A.
  • TABLE 160 Key Information - Zealand Pharma A/S
  • TABLE 161 key Information - B. Braun Melsungen AG
  • TABLE 162 Key Information - Bayer AG
  • TABLE 163 Key Information - Abbott Laboratories
  • TABLE 164 Key Information --Ypsomed AG
  • TABLE 165 Key Information - Arkray, Inc.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
  • FIG 4 Key Strategic Move: (Partnerships, collaborations and agreements : 2018, oct - 2022, may) Leading Players
  • FIG 5 Global Diabetes Care Devices Market Share, By Product, 2021
  • FIG 6 Global Diabetes Care Devices Market Share, By Product, 2028
  • FIG 7 Global Diabetes Care Devices Market Size, By Product, 2018 - 2028, USD Million
  • FIG 8 Global Diabetes Care Devices Market Share, By Region, 2021
  • FIG 9 Global Diabetes Care Devices Market Share, By Region, 2028
  • FIG 10 Global Diabetes Care Devices Market Size, By Region, 2018 - 2028, USD Million
  • FIG 11 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
  • FIG 12 Recent strategies and developments: DexCom, Inc.
  • FIG 13 Recent strategies and developments: Novo Nordisk A/S
  • FIG 14 Recent strategies and developments: Sanofi S.A.
  • FIG 15 Recent strategies and developments: Zealand Pharma A/S
  • FIG 16 Recent strategies and developments: Arkray, Inc.